Institutes
Refine
Year of publication
Document Type
- Article (278) (remove)
Has Fulltext
- yes (278)
Is part of the Bibliography
- no (278)
Keywords
- RNA (10)
- SARS-CoV-2 (10)
- NMR spectroscopy (8)
- photochemistry (8)
- Cell biology (7)
- inflammation (7)
- Biochemistry (6)
- NMR (6)
- X-ray crystallography (6)
- Alzheimer’s disease (5)
- COVID19-NMR (4)
- DNA-PAINT (4)
- fluorescence (4)
- neurodegeneration (4)
- photolabile protecting groups (4)
- Antimicrobial resistance (3)
- Biophysical chemistry (3)
- Mass spectrometry (3)
- Non-structural protein (3)
- RNA structures (3)
- Solution NMR spectroscopy (3)
- Solution NMR-spectroscopy (3)
- acetylcholine (3)
- drug discovery (3)
- hippocampus (3)
- machine learning (3)
- mass spectrometry (3)
- membrane proteins (3)
- microdialysis (3)
- nuclear receptor (3)
- oligonucleotides (3)
- optogenetics (3)
- pain (3)
- polypharmacology (3)
- structural biology (3)
- 5′-UTR (2)
- 6-shogaol (2)
- ABC transporter (2)
- Bacterial biofilms (2)
- Bacterial structural biology (2)
- Baird's rule (2)
- Cancer (2)
- Chemical tools (2)
- Chromones (2)
- Covid19-NMR (2)
- Cryoelectron microscopy (2)
- DNA (2)
- Endothelial cells (2)
- Enzyme mechanisms (2)
- G-quadruplexes (2)
- Host-biofilm interactions (2)
- Inflammation (2)
- Innate immune response (2)
- MLL (2)
- Mechanisms of disease (2)
- Medicinal chemistry (2)
- NR4A2 (2)
- PROTAC (2)
- Permeation and transport (2)
- Persistent wound infections (2)
- Protein drugability (2)
- RNA modification (2)
- RNA processing (2)
- SL1 (2)
- SiGe alloys (2)
- Solution-state NMR (2)
- Structural biology (2)
- Zingiber officinale Roscoe (2)
- accessibility switch (2)
- actin (2)
- ankyrin (2)
- aptamers (2)
- autophagy (2)
- boron (2)
- boryl anions (2)
- boswellic acids (2)
- click chemistry (2)
- cluster compounds (2)
- computational chemistry (2)
- dorsal root ganglia (2)
- epigenetics (2)
- erythrocyte (2)
- excited state aromaticity (2)
- farnesoid X receptor (2)
- fluorescent probes (2)
- fluorine (2)
- fragment screening (2)
- germanium (2)
- glucose (2)
- inward proton pump (2)
- lactate (2)
- malaria (2)
- microbial rhodopsin (2)
- microscopy (2)
- mitochondrial respiration (2)
- molecular dynamics (2)
- non-alcoholic steatohepatitis (2)
- phosphorylation (2)
- photoisomerization (2)
- protein structure (2)
- reactive oxygen species (2)
- rearrangements (2)
- rhodopsin (2)
- silicon (2)
- similarity measures (2)
- single-particle tracking (2)
- skin infection model (2)
- spinal cord (2)
- substituent effects (2)
- subvalent compounds (2)
- tRNA splicing (2)
- time-resolved spectroscopy (2)
- transcription factor (2)
- virulence factor (2)
- 1,3-diamine (1)
- 10-Hydroxyaloins A/B (1)
- 140Ce (1)
- 19F (1)
- 2'-deoxyguanosine riboswitch (1)
- 2D NMR spectroscopy (1)
- 2′-O-methylation (1)
- 3D electron diffraction (1)
- 3D reconstruction and image processing (1)
- 4-fluoroamphetamine (1)
- 5'-UTR (1)
- 5-lipoxygenase (1)
- 5-lipoxygenase; (1)
- 9-borafluorene (1)
- ABC Transporter (1)
- ABC proteins, ribosome recycling (1)
- ABC transporters (1)
- ADAR (1)
- AF4 (1)
- AF4–MLL (1)
- AMP-activated kinase (AMPK) (1)
- ATG4 (1)
- ATG8 (1)
- ATP binding (1)
- ATPases (1)
- ATTO 390 (1)
- Ab initio calculations (1)
- Adenosine A1 receptor (1)
- Age (1)
- Alkylation of RNA (1)
- Aloe (1)
- Aloe lateritia ENGLER (1)
- Alzheimer's disease (1)
- Analytical chemistry (1)
- Angiogenesis (1)
- Anthranoids (1)
- Anthraquinones (1)
- Anthrones (1)
- Antigen processing and presentation (1)
- Antimuscarinic and Papaverine-Like Activity (1)
- Antisense agents (1)
- Apoptosis (1)
- Arc protein (1)
- Armadillo repeat protein (1)
- Asphodelaceae (1)
- Assignment (1)
- Atg8 (1)
- Aurora kinase (1)
- BACE1 (1)
- BET proteins (1)
- BH3 mimetics (1)
- Bacterial Signal Transduction (1)
- Bacterial biofilm (1)
- BioID (1)
- Bioenergetics (1)
- Biological techniques (1)
- Biomaterials – proteins (1)
- Biotechnology (1)
- Brain (1)
- Bärnighausen tree (1)
- B−B bonds (1)
- B−H bonds (1)
- C. elegans (1)
- CEST (1)
- CNN (1)
- COVID-19 (1)
- CPVT (1)
- CRBN (1)
- Caenorhabditis elegans (1)
- Calstabin2/FKBP12.6 (1)
- Cancer models (1)
- Capsule Synthesis (1)
- Carbanions (1)
- Catalysis (1)
- Cell division (1)
- Cellular microbiology (1)
- Chaperones (1)
- Chemical modification (1)
- Chemistry (1)
- Clinical relevant dissolution specification (1)
- Colorectal cancer (1)
- Complex I (1)
- Complex II (1)
- Computational biology and bioinformatics (1)
- Covid19-nmr (1)
- Crystal and Molecular Structure (1)
- Curcuminoid concentrations (1)
- Cy5.5 (1)
- Cyclization (1)
- CysLTR1 (1)
- Cysteine‐Rich Domain (CRD) (1)
- DFT+MBD calculations (1)
- DNA G-quadruplex (1)
- DNA conjugate (1)
- DNA damage response (1)
- DNA methylation (1)
- DNA pulldown (1)
- DNA recognition (1)
- DNA-protein-interactions (1)
- DNP in solids (1)
- Degrader design (1)
- DiI (1)
- Diseases (1)
- Dissolution nanoparticles (1)
- Disulfide bond (1)
- Disulphide Bridges (1)
- Drug delivery systems (1)
- Drug discovery (1)
- Drug screening (1)
- Dynamics (1)
- E3 Ligase (1)
- EGFR (1)
- EPR spectroscopy (1)
- ERK3 (1)
- Entwicklungsbiologie (1)
- FBDD (1)
- FBS (1)
- FPR (1)
- Flash photolysis (1)
- Food effect (1)
- Fortpflanzung (1)
- Fragment (1)
- Functional aspects of cell biology (1)
- Fusion proteins (1)
- G protein-coupled receptors (1)
- G-protein-coupled receptors (1)
- G-quadruplex binders (1)
- GABARAP (1)
- GIIb/IIIa-receptor (1)
- GdIr2Si2 (1)
- Genetic engineering (1)
- Genetics (1)
- Glucose (1)
- Glutathione (1)
- Gβγ subunit (1)
- HIV protease inhibitors (1)
- Haloferax volcanii (1)
- HeLa cells (1)
- Herpes Simplex Virus Type 1 (HSV-1) (1)
- Heterocycles (1)
- High Performance Liquid (1)
- Histidine Kinases (1)
- Homeoviscous adaptation (1)
- Homonataloins A and B (1)
- IAP (1)
- INS (1)
- Image processing (1)
- Immune evasion (1)
- Immunochemistry (1)
- Immunology (1)
- In situ hybridization (1)
- In vitro wound models (1)
- Infectious diseases (1)
- Instrumentation & Devices (1)
- Ion transport (1)
- Isolation, separation and purification (1)
- Jurkat (1)
- K48-linked (1)
- K63-linked (1)
- KMT2A (1)
- Knotless phytochrome (1)
- LASS (1)
- LC-MS-based lipid mediator analysis (1)
- LC3 (1)
- LC3/GABARAP (1)
- LILBID-MS (1)
- LIMK1 (1)
- LIMK2 (1)
- LIR (1)
- LIR motif (1)
- Leukaemia (1)
- Leukocytes (1)
- Lewis acid (1)
- Ligands (1)
- Lipid packing (1)
- Lipoprotein Structure (1)
- Liposomes (1)
- MACS (1)
- MAPK6 (1)
- MET (1)
- MET receptor (1)
- MLL-r acute leukemia (1)
- MODY (1)
- Macrodomain (1)
- Membrane Proteins (1)
- Membrane fluidity (1)
- Membrane homeostasis (1)
- Membrane proteins (1)
- Membranes (1)
- Metabolic Regulation (1)
- Mice (1)
- Microbiology (1)
- Microdialysis (1)
- Mitochondrial dysfunction (1)
- Mitosis (1)
- Modification (1)
- Molecular Interactions (1)
- Molecular biology (1)
- Molecular glue (1)
- Multidrug Transporters (1)
- Multiphoton microscopy (1)
- Mycobacterium tuberculosis (1)
- NADPH oxidase (1)
- NASH (1)
- NMR Solution Structure (1)
- NMR solution structure (1)
- NMRI (1)
- NOESY (1)
- NR4A3 (1)
- NanoBRET (1)
- Nanocarriers (1)
- Natural product (1)
- Natural products (1)
- Neuropathic pain (1)
- New E3-ligase ligands (1)
- Nox (1)
- Nox inhibition (1)
- Nucleic acid-binding domain (1)
- Nucleolar protein 14 (1)
- Oncogenes (1)
- Oncoprotein activation (1)
- Orphan nuclear receptor (1)
- Outer Membrane Protein RcsF (1)
- Overhauser effect (1)
- Oxanthrone Glucosyls (1)
- Oxidative phosphorylation (1)
- PAC-1 (1)
- PBPK (1)
- PBPK modelling (1)
- PBPK/PD (1)
- PC12APPsw (1)
- PDF-Global-Fit (1)
- PELDOR/DEER spectroscopy (1)
- PIM kinases (1)
- PLGA nanoparticles (1)
- PXRD (1)
- Pain behavior (1)
- Parkinson’s disease (1)
- Partial agonist (1)
- Patch-clamp (1)
- Peptide nucleic acids (1)
- Pharmacology (1)
- Photochemistry (1)
- Photosynthesis (1)
- Physical chemistry (1)
- Pigment Green 7 (1)
- Polyketides (1)
- Post-Hartree-Fock methods (1)
- Potassium channels (1)
- Pre‐Ligand Assembly Domain (PLAD) (1)
- Protein biosynthesis (1)
- Protein folding (1)
- Protein synthesis (1)
- Proteins (1)
- Pseudocontact shift (1)
- QbD (1)
- Quality control (1)
- Quinonoids (1)
- R values (1)
- RNA PT (1)
- RNA cleavage (1)
- RNA degradation (1)
- RNA dynamics (1)
- RNA modifications (1)
- RNA synthesis (1)
- RNA therapy (1)
- RNA-binding proteins (1)
- RND (1)
- Rab27a (1)
- Radiotherapy (1)
- Regulation of lipid metabolism (1)
- Release testing (1)
- Rh(II) catalysis (1)
- Rhabdomyosarcoma (1)
- Rhamnus purshianus D. C. (1)
- Ribosome biogenesis (1)
- Rietveld refinement (1)
- RyR2 (1)
- S107 (1)
- SAR (1)
- SEDDS (1)
- SHAPE analysis (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- SMEDDS (1)
- SNEDDS (1)
- SNP (1)
- SOFI (1)
- SPM (1)
- STED microscopy (1)
- Saccharomyces cerevisiae (1)
- Semi-empiricalcalculations (1)
- Sexualität (1)
- Sila-Substitution (1)
- Silacyclobutenes (1)
- Silylation (1)
- Single-Molecule Localization Microscopy (SMLM) (1)
- Small molecules (1)
- Solubility (1)
- Stem-cell research (1)
- Stereochemistry (1)
- Stroke (1)
- Structural Biology (1)
- Structure refinement (1)
- T-cell (1)
- TBK1 (1)
- TERRA RNA (1)
- TICT (1)
- TSEN (1)
- Target validation (1)
- Taspase1 (1)
- TgF344-AD (1)
- Theoretical chemistry (1)
- Time-resolved spectroscopy (1)
- Tissue distribution (1)
- TmRh2Si2 (1)
- Transcription factors (1)
- Transport Drugs (1)
- Transporters (1)
- Tumour-suppressor proteins (1)
- Two-component System (1)
- UBA5 (1)
- UBL (1)
- UFIM (1)
- UFM1 (1)
- ULK4 (1)
- UV/Vis spectroscopy (1)
- Ubiquitin (1)
- Unc-51-like kinase (1)
- VHL (1)
- Vioprolide A (1)
- Wound dressings (1)
- Wound infection (1)
- X-ray structure analysis (1)
- Xenocoumacin (1)
- Zolpidem (1)
- absolute quantification of RNA modifications (1)
- ab initio calculations (1)
- accessory proteins (1)
- actin cytoskeleton dynamics (1)
- acute leukemia (1)
- acyclovir (1)
- adaptor mediated recruitment (1)
- additive manufacturing (1)
- adenosine–arginine conjugate (1)
- adenylyl cyclases (1)
- aging (1)
- alternative matrices (1)
- amyloid beta (1)
- amyloid precursor protein (1)
- analgesia (1)
- analytical chemistry (1)
- angiogenesis-related cell functions (1)
- anilinopyrimidine (1)
- antibiotic resistance (1)
- antigen presentation (1)
- antigen processing (1)
- antisense technology (1)
- antiviral response (1)
- antiviral signaling (1)
- apoptosis (1)
- aptamer (1)
- arachidonic acid (AA) (1)
- arrhythmia model (1)
- astrogliosis (1)
- atropisomers (1)
- attention module (1)
- atypical MAPK kinase (1)
- automated assignment (1)
- axon bifurcation (1)
- axon branching (1)
- azo compounds (1)
- baicalein (1)
- barstar (1)
- benchmark standards (1)
- benzazepinone (1)
- benzothiazoles (1)
- big data (1)
- bilin-binding photoreceptors (1)
- bioavailability (1)
- bioconjugation (1)
- bioequivalence (1)
- biomarker (1)
- biophysics (1)
- bioprinting (1)
- biorelevant dissolution (1)
- bisubstrate inhibitors (1)
- body-on-a-chip (1)
- bond activation (1)
- boron heterocycles (1)
- breast milk (1)
- brightness (1)
- buchu (1)
- c-Myc (1)
- cGMP signalling (1)
- calsequestrin (1)
- cancer (1)
- canine cancer (1)
- capture (1)
- carbazole ligands (1)
- carbon direct detection (1)
- catalytic mechanism (1)
- cell cycle (1)
- cell stress (1)
- cell-free expression (1)
- cell-free protein synthesis (1)
- cellular uptake and localization (1)
- ceramide synthase (1)
- cerium (1)
- cerumen (1)
- channelrhodopsin (1)
- charge transfer (1)
- chemical shift assignment (1)
- chemiluminescence (1)
- chemoenzymatic synthesis (1)
- chemogenomics (1)
- cholesterol (1)
- chronobiology (1)
- circular dichroism (1)
- clustering (1)
- co-crystal structure (1)
- coarse-grained simulations (1)
- cofilin (1)
- colon (1)
- combinatorial approaches (1)
- commercialization (1)
- comparative oncology (1)
- complex I (1)
- complex IV (1)
- computer-aided diagnosis (1)
- conductivity (1)
- confocal Raman microscopy (1)
- confocal microscopy (1)
- connection to nature (1)
- continuous rotation (1)
- copper phthalocyanine (1)
- correlated electrons (1)
- coumarin (1)
- coumarin 6 (1)
- covalent inhibitors (1)
- creams (1)
- cross-correlation functions (1)
- cross-section (1)
- cryo-electron microscopy (1)
- crystal structure (1)
- curcumin (1)
- cyanines (1)
- cyclic nucleotide-gated channels (1)
- cycloaddition (1)
- cysteine reactivity (1)
- cysteine-redox regulation (1)
- cytokine (1)
- data curation (1)
- data projection (1)
- data science (1)
- de novo design (1)
- deep learning (1)
- dendritic spines (1)
- de novo design (1)
- dialysis (1)
- diazo compounds (1)
- diboranes (1)
- differential scanning fluorimetry (1)
- diffusion states (1)
- digestion artifact (1)
- dissolution (1)
- dopamine D2S/D3 receptor (1)
- drug abstinence (1)
- drug metabolism and distribution (1)
- drug release (1)
- drug resistance (1)
- drug targets (1)
- drug therapy (1)
- drug-likeness (1)
- dynamic nuclear polarization (1)
- efflux pump (1)
- eicosanoid (1)
- electron crystallography (1)
- electron transfer system (1)
- electronic nose (1)
- enamides (1)
- end maturation (1)
- endolysosomal system (1)
- endonuclease (1)
- endoplasmic reticulum (1)
- endothelial cells (1)
- energy barriers (1)
- enolase-1 (1)
- environmental education (1)
- enzyme catalysis (1)
- enzyme kinetics (1)
- epitranscriptome (1)
- epitranscriptomics (1)
- ethnobotany (1)
- evolution (1)
- extract (1)
- famotidine (1)
- fatty acid (1)
- fatty acid/biosynthesis (1)
- filopodia (1)
- flavolignan (1)
- fluidity (1)
- fluorescent labeling (1)
- fluorophore (1)
- flux growth (1)
- folding landscapes (1)
- food effect (1)
- fragment-based design (1)
- fragment-based drug design (1)
- fragment-based screening (1)
- frankincense (1)
- fulgide (1)
- gallein (1)
- gapmers (1)
- gene expression (1)
- genetic code expansion (1)
- glucose transport (1)
- glutathione (1)
- glutathionylation (1)
- glycolysis (1)
- green gap (1)
- guanidine riboswitch (1)
- guanidine-II riboswitch (1)
- guanylyl cyclases (1)
- hairpin polyamides (1)
- heart-on-a-chip (1)
- hepatocyte nuclear factor 4α (1)
- heteronuclear detection (1)
- hierarchical clustering (1)
- high content imaging (1)
- high dimensional complex data (1)
- high-throughput sequencing (1)
- histamine (1)
- histone deacetylase (1)
- histone modifications (1)
- homogeneous catalysis (1)
- human milk (1)
- human neurons (1)
- human pain models (1)
- human pharmacology (1)
- hxt0 strain (1)
- hydromethylthionine (1)
- hypoxia (1)
- iPSc (1)
- immune system (1)
- in vitro activities (1)
- in vivo neuroimaging (1)
- in-vitro–in-vivo correlation (1)
- infant health (1)
- interaction partners (1)
- interest in animals (1)
- interface engineering (1)
- intracellular internalization (1)
- intrinsically disordered region (1)
- inflammatory pain (1)
- ionization (1)
- isopropanol (1)
- isothermal titration calorimetry (ITC) (1)
- isotope labeling (1)
- itch (1)
- kidney-on-a-chip (1)
- kinase (1)
- kinase inhibitors (1)
- kinetics (1)
- labelfree quantitative mass spectrometry (1)
- leucocytes (1)
- leukotriene (1)
- leukotriene A4 hydrolase (1)
- ligand design (1)
- ligases (1)
- light control (1)
- light-induced polymerization (1)
- lipid (1)
- lipid based formulation (1)
- lipid suspension (1)
- lipidomics (1)
- liposomes (1)
- lipoxin (1)
- lipoxygenase (1)
- lipoxygenase inhibitor (1)
- liquid chromatography–mass spectrometry (1)
- liver fibrosis (1)
- liver-on-a-chip (1)
- lung cancer (1)
- lung tumor heterogeneity (1)
- lung-on-a-chip (1)
- lysosome (1)
- lysosomes (1)
- mRNA surveillance (1)
- macromolecular machines (1)
- macrophage (1)
- magnetic resonance imaging (1)
- magnetism (1)
- main group elements (1)
- maternal diet (1)
- mature milk (1)
- meat adulteration (1)
- medicinal chemistry (1)
- medicinal plant (1)
- memantine (1)
- membrane mimics (1)
- membrane organization (1)
- membrane receptors (1)
- membranes/fluidity (1)
- memory consolidation (1)
- metabolic sydrome (1)
- metabolomics (1)
- metallo β lactamases (1)
- mice (1)
- micro-physiological systems (1)
- microRNA (1)
- microsomal prostaglandin E2 (1)
- mitochondria (1)
- mixed valence compounds (1)
- molecular docking (1)
- molecular electronics (1)
- molecular machines (1)
- molecular switch (1)
- multi-objective optimization (1)
- multi-target drug (1)
- multi-task learning (1)
- multicolor imaging (1)
- multidrug resistance protein 4 (1)
- multiple sclerosis (1)
- multiresistant bacteria (1)
- multispectral flow cytometry (1)
- multitarget drugs (1)
- multitasking protein (1)
- n_TOF (1)
- nanodiscs (1)
- nanomedicine (1)
- natural compound synthesis (1)
- neural network (1)
- neurodegenerative disorders (1)
- neuromuscular system (1)
- neuropathy (1)
- neurotropic virus (1)
- neutron (1)
- nitrogen direct detection (1)
- nitroindoles (1)
- nitrosylation (1)
- nociception (1)
- non-alcoholic fatty liver disease (1)
- non-canonical amino acid (1)
- non-coding RNAs (1)
- non-invasive imaging (1)
- non-natural nucleotide (1)
- nonstructural proteins (1)
- nuclear magnetic resonance (NMR) (1)
- nuclear magnetic resonance spectroscopy (1)
- nuclear receptor related-1 (1)
- nuclear receptor-related 1 (1)
- nucleobases (1)
- nucleophilic boron (1)
- nucleophilic substitution (1)
- nucleoside analysis (1)
- nucleosynthesis (1)
- oligonucleotide (1)
- oncogene promoters (1)
- one-dimensional convolutional neural network (1)
- one-pot reaction (1)
- optogenetic (1)
- organs-on-a-chip (1)
- osteopontin (1)
- oxidative folding (1)
- pSer domain (1)
- pair distribution function analysis (1)
- pair distribution functions (1)
- pancreatic cancer (1)
- peptide antibiotics (1)
- peptide transport (1)
- performance tests (1)
- peripheral injury (1)
- peroxisome prolifer ators-activated receptor-γ (1)
- phage lysis proteins (1)
- pharmacological activity (1)
- pharmacophore model (1)
- phase separation (1)
- phenotypic screening (1)
- phospholipids/phosphatidylglycerol (1)
- photo-tethering (1)
- photoacid (1)
- photobleaching (1)
- photocage (1)
- photocaging (1)
- photocycle (1)
- photoswitch (1)
- phototherapeutic window (1)
- phytochemical composition (1)
- phytochromes (1)
- platelets (1)
- polymers (1)
- polyubiquitin (1)
- potassium (1)
- powder data (1)
- precipitation inhibitor (1)
- privileged structures (1)
- proline isomerization (1)
- prostaglandin (1)
- prostaglandin E (1)
- prostaglandins (1)
- protein X-ray crystallography (1)
- protein capture (1)
- protein compartmentalization (1)
- protein engineering (1)
- protein folding (1)
- protein kinase inhibitor (1)
- protein motif (1)
- protein oxidation (1)
- protein tyrosine phosphatase (1)
- protein-protein interactions (1)
- proteins (1)
- proton transfer (1)
- pseudokinase (1)
- pseudouridylation (1)
- purification of protein complexes (1)
- quantum yield (1)
- quercetin (1)
- radical reactions (1)
- random forest regressor (1)
- real-time NMR spectroscopy (1)
- receptor condensates (1)
- receptor cross-interaction (1)
- receptor dynamics (1)
- receptor tyrosine kinases (1)
- red light (1)
- redox chemistry (1)
- release testing (1)
- resmetirom (1)
- resolution of inflammation (1)
- resolvin (1)
- resveratrol (1)
- retinal (1)
- retinoid X receptor (1)
- rhodamine 123 (1)
- ribosomal exit tunnel (1)
- ribosome-associated quality control (1)
- riboswitch (1)
- ribozymes (1)
- rivastigmine (1)
- s-process (1)
- screening system (1)
- self-assembled monolayers (1)
- self-initiated photografting and photopolymerization (1)
- semisolids (1)
- siRNAs (1)
- signal transduction (1)
- silibinin (1)
- silybin (1)
- single-molecule FRET (1)
- single-molecule imaging (1)
- single-molecule localization microscopy (1)
- single-particle cryoEM (1)
- single-trajectory analysis (1)
- site-directed spin labeling (1)
- site-specific labeling (1)
- skin delivery (1)
- skin-on-a-chip (1)
- small protein (1)
- small-molecule inhibitor (1)
- smooth muscle cells (1)
- sodium alkoxide (1)
- solid-phase synthesis (1)
- solid-state NMR spectroscopy (1)
- soluble epoxide hydrolase (1)
- solvate (1)
- somatosensory system (1)
- soraphen (1)
- spiro compounds (1)
- splice-modulating oligonucleotides (1)
- stability of fluorescent label (1)
- stearic acid (1)
- stereoselective synthesis (1)
- streptozotocin (1)
- stress dependent RNA modification dynamics (1)
- structural proteins (1)
- structure determination (1)
- structure-activity relationships (1)
- sugar transport assays (1)
- sugar transport inhibitors (1)
- sulfamide (1)
- super-SMEDDS (1)
- super-SNEDDS (1)
- super-resolution microscopy (1)
- supersaturating drug delivery systems (1)
- supersaturation (1)
- surface modification (1)
- surface-initiated polymerization (1)
- surfactant (1)
- swelling (1)
- synthase-1 (1)
- t(4;11) leukemia (1)
- tRNA (1)
- target variability (1)
- temperature jump (1)
- tetrapyrrole-binding photoreceptors (1)
- therapy (1)
- thermal stability (1)
- thiol inhibitors (1)
- thyroid hormone receptor (1)
- tissue distribution (1)
- tissue-plasma-ratio (1)
- toll-like receptor (1)
- topical formulations (1)
- total scattering technique (1)
- total scattering techniques (1)
- trafficking (1)
- transcription (1)
- transient complex (1)
- tumor (1)
- tumor microenvironment (1)
- type 2 diabetes (1)
- ubiquitin-conjugating enzymes (1)
- ultrafast spectroscopy (1)
- umpolung (1)
- validation (1)
- vascular biology (1)
- vascular biology/endothelial cells (1)
- venetoclax (1)
- viral immune escape (1)
- virus (1)
- vitamin B12 (1)
- weakly supervised learning (1)
- x-ray crystallography (1)
- yeast fatty acid synthase (1)
- zinc finger (1)
- zolpidem (1)
- zoo education (1)
- µ-protein (1)
Institute
- Biochemie, Chemie und Pharmazie (278)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (30)
- Medizin (26)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (22)
- Biowissenschaften (15)
- MPI für Biophysik (9)
- Physik (7)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (5)
- Exzellenzcluster Makromolekulare Komplexe (3)
- MPI für Hirnforschung (2)
5‐Lipoxygenase (5‐LO) is the initial enzyme in the biosynthesis of leukotrienes, which are mediators involved in pathophysiological conditions such as asthma and certain cancer types. Knowledge of proteins involved in 5‐LO pathway regulation, including gene regulatory proteins, is needed to evaluate all options for therapeutic intervention in these diseases. Here, we present a mass spectrometric screening of ALOX5 promoter‐interacting proteins, obtained by DNA pulldown and label‐free quantitative mass spectrometry. Protein preparations from myeloid and B‐lymphocytic cell lines were screened for promoter DNA interactors. Through statistical analysis, 66 proteins were identified as specific ALOX5 promotor binding proteins. Among those, the 15 most likely candidates for a prominent role in ALOX5 gene regulation are the known ALOX5 interactors Sp1 and Sp3, the related factor Sp2, two Krüppel‐like factors (KLF13 and KLF16) and six other zinc finger proteins (MAZ, PRDM10, VEZF1, ZBTB7A, ZNF281 and ZNF579). Intriguingly, we also identified two helicases (BLM and DHX36) and the proteins hnRNPD and hnRNPK, which are, together with the protein MAZ, known to interact with DNA G‐quadruplex structures. As G‐quadruplexes are implicated in gene regulation, spectroscopic and antibody‐based methods were used to confirm their presence within the GC‐rich sequence of the ALOX5 promoter. In summary, we have systematically characterized the interactome of the ALOX5 promoter, identifying several zinc finger proteins as novel potential ALOX5 gene regulators. Further, we have shown that the ALOX5 promoter can form DNA G‐quadruplex structures, which may play a functional role in ALOX5 gene regulation.
Background: Zolpidem is a non-benzodiazepine hypnotic agent which has been shown to be effective in inducing and maintaining sleep in adults and is one of the most frequently prescribed hypnotics in the world. For drugs that are used to treat sleeping disorders, the time to reach the maximum concentration (Tmax) of the drug in plasma is important to achieving a fast onset of action and this must be maintained when switching from one product to another.
Objectives: The main objective of the present work was to create a PBPK/PD model for zolpidem and establish a clinically relevant “safe space” for dissolution of zolpidem from the commercial immediate release (IR) formulation. A second objective was to analyze literature pharmacokinetic data to verify the negative food effect ascribed to zolpidem and consider its ramifications in terms of the “safe space” for dissolution.
Methods: Using dissolution, pharmacokinetic and pharmacodynamic data, an integrated PBPK/PD model for immediate release zolpidem tablets was constructed in Simcyp®. This model was used to identify the clinically relevant dissolution specifications necessary to ensure efficacy.
Results: According to the simulations, as long as 85% of the drug is released in 45 minutes or less, the impact on the PK and PD profiles of zolpidem would be minimal. According to the FDA, the drug has to dissolve from the test and reference products at a similar rate and to an extent of 85% in not more than 30 minutes to pass bioequivalence via the BCS-biowaiver test. Thus, the BCS-biowaiver specifications are somewhat more stringent than the “safe space” based on the PBPK/PD model. Published data from fasted and fed state pharmacokinetic studies suggest but do not prove a negative food effect of zolpidem.
Conclusions: A PBPK/PD model indicates that current BCS biowaiver criteria are more restrictive for immediate release zolpidem tablets than they need to be. In view of the close relationship between PK and PD, it remains advisable to avoid taking zolpidem tablets with or immediately after a meal, as indicated by the Stilnox® labeling.
Nuclear receptor related 1 (Nurr1) is an orphan ligand-activated transcription factor and considered as neuroprotective transcriptional regulator with great potential as therapeutic target for neurodegenerative diseases. However, the collection of available Nurr1 modulators and mechanistic understanding of Nurr1 are limited. Here, we report the discovery of several structurally diverse non-steroidal anti-inflammatory drugs as inverse Nurr1 agonists demonstrating that Nurr1 activity can be regulated bidirectionally. As chemical tools, these ligands enable unraveling the co-regulatory network of Nurr1 and the mode of action distinguishing agonists from inverse agonists. In addition to its ability to dimerize, we observe an ability of Nurr1 to recruit several canonical nuclear receptor co-regulators in a ligand-dependent fashion. Distinct dimerization states and co-regulator interaction patterns arise as discriminating factors of Nurr1 agonists and inverse agonists. Our results contribute a valuable collection of Nurr1 modulators and relevant mechanistic insights for future Nurr1 target validation and drug discovery.
Atg8-family proteins - structural features and molecular interactions in autophagy and beyond
(2020)
Autophagy is a common name for a number of catabolic processes, which keep the cellular homeostasis by removing damaged and dysfunctional intracellular components. Impairment or misbalance of autophagy can lead to various diseases, such as neurodegeneration, infection diseases, and cancer. A central axis of autophagy is formed along the interactions of autophagy modifiers (Atg8-family proteins) with a variety of their cellular counter partners. Besides autophagy, Atg8-proteins participate in many other pathways, among which membrane trafficking and neuronal signaling are the most known. Despite the fact that autophagy modifiers are well-studied, as the small globular proteins show similarity to ubiquitin on a structural level, the mechanism of their interactions are still not completely understood. A thorough analysis and classification of all known mechanisms of Atg8-protein interactions could shed light on their functioning and connect the pathways involving Atg8-proteins. In this review, we present our views of the key features of the Atg8-proteins and describe the basic principles of their recognition and binding by interaction partners. We discuss affinity and selectivity of their interactions as well as provide perspectives for discovery of new Atg8-interacting proteins and therapeutic approaches to tackle major human diseases.
Tissue injury and inflammation may result in chronic pain, a severe debilitating disease that is associated with great impairment of quality of life. An increasing body of evidence indicates that members of the Rab family of small GTPases contribute to pain processing; however, their specific functions remain poorly understood. Here, we found using immunofluorescence staining and in situ hybridization that the small GTPase Rab27a is highly expressed in sensory neurons and in the superficial dorsal horn of the spinal cord of mice. Rab27a mutant mice, which carry a single-nucleotide missense mutation of Rab27a leading to the expression of a nonfunctional protein, show reduced mechanical hyperalgesia and spontaneous pain behavior in inflammatory pain models, while their responses to acute noxious mechanical and thermal stimuli is not affected. Our study uncovers a previously unrecognized function of Rab27a in the processing of persistent inflammatory pain in mice.
Receptor tyrosine kinases (RTKs) orchestrate cell motility and differentiation. Deregulated RTKs may promote cancer and are prime targets for specific inhibitors. Increasing evidence indicates that resistance to inhibitor treatment involves receptor cross-interactions circumventing inhibition of one RTK by activating alternative signaling pathways. Here, we used single-molecule super-resolution microscopy to simultaneously visualize single MET and epidermal growth factor receptor (EGFR) clusters in two cancer cell lines, HeLa and BT-20, in fixed and living cells. We found heteromeric receptor clusters of EGFR and MET in both cell types, promoted by ligand activation. Single-protein tracking experiments in living cells revealed that both MET and EGFR respond to their cognate as well as non-cognate ligands by slower diffusion. In summary, for the first time, we present static as well as dynamic evidence of the presence of heteromeric clusters of MET and EGFR on the cell membrane that correlates with the relative surface expression levels of the two receptors
Zoos attract millions of visitors every year, many of whom are schoolchildren. For this reason, zoos are important institutions for the environmental education of future generations. Empirical studies on the educational impact of environmental education programs in zoos are still rare. To address this issue, we conducted two studies: In study 1, we investigated students’ interests in different biological topics, including zoos (n = 1,587). Data analysis of individual topics revealed large differences of interest, with advanced students showing less interest in zoos. In study 2, we invited school classes of this age group to visit different guided tours at the zoo and tested connection to nature before and after each educational intervention (n = 608). The results showed that the guided tours are an effective tool to raise students’ connection to nature. Add-on components have the potential to further promote connection to nature. The education programs are most effective with students with a low initial nature connection.
Most fungal fatty acid synthases assemble from two multidomain subunits, α and β, into a heterododecameric FAS complex. It has been recently shown that the complex assembly occurs in a cotranslational manner and is initiated by an interaction between the termini of α and β subunits. This initial engagement of subunits may be the rate-limiting phase of the assembly and subject to cellular regulation. Therefore, we hypothesized that bypassing this step by genetically fusing the subunits could be beneficial for biotechnological production of fatty acids. To test the concept, we expressed fused FAS subunits engineered for production of octanoic acid in Saccharomyces cerevisiae. Collectively, our data indicate that FAS activity is a limiting factor of fatty acid production and that FAS fusion proteins show a superior performance compared to their split counterparts. This strategy is likely a generalizable approach to optimize the production of fatty acids and derived compounds in microbial chassis organisms.
The quarternary, trimethylated amine glycine betaine (GB) is widespread in nature but its fate under anoxic conditions remains elusive. It can be used by some acetogenic bacteria as carbon and energy source but the pathway of GB metabolism has not been elucidated. We have identified a gene cluster involved in GB metabolism and studied acetogenesis from GB in the model acetogen Acetobacterium woodii . GB is taken up by a secondary active, Na+ coupled transporter of the betaine‐choline‐carnitine (BCC) family. GB is demethylated to dimethylglycine, the end product of the reaction, by a methyltransferase system. Further conversion of the methyl group requires CO2 as well as Na+ indicating that GB metabolism involves the Wood‐Ljungdahl pathway. These studies culminate in a model for the path of carbon and electrons during acetogenensis from GB and a model for the bioenergetics of acetogenesis from GB.
Methanol derived from plant tissue is ubiquitous in anaerobic sediments and a good substrate for anaerobes growing on C1 compounds such as methanogens and acetogens. In contrast to methanogens little is known about the physiology, biochemistry and bioenergetics of methanol utilization in acetogenic bacteria. To fill this gap, we have used the model acetogen Acetobacterium woodii to study methanol metabolism using physiological and biochemical experiments paired with molecular studies and transcriptome analysis. These studies identified the genes and enzymes involved in acetogenesis from methanol and the redox carriers involved. We will present the first comprehensive model for carbon and electron flow from methanol in an acetogen and the bioenergetics of acetogenesis from methanol.
Objectives: The main objective of the present work was to combine in vitro and in silico tools to better understand the in vivo behavior of the immediate release (IR) formulation of zolpidem in the fasted and fed states.
Methods: The dissolution of zolpidem was evaluated using biorelevant media simulating the gastric and intestinal environment in the fasted and fed states. Additionally, the influence of high viscosity and high fat content on the release of zolpidem under fed state conditions was investigated. The in vitro results were combined with a physiologically based pharmacokinetic (PBPK) model constructed with Simcyp to simulate the zolpidem pharmacokinetic profile in both prandial states.
Key findings: In vitro biorelevant dissolution experiments representing the fasted and fed states, combined with PBPK modelling, were able to simulate the plasma profiles from the clinical food effect studies well. Experiments reflecting the pH and fat content of the meal led to a good prediction of the zolpidem plasma profile in the fed state, whereas increasing the viscosity of the gastric media led to an under-prediction.
Conclusions: This work demonstrates that the combination of biorelevant dissolution testing and PBPK modelling is very useful for understanding the in-vivo behavior of zolpidem in the fasted and fed states. This approach could be implemented in the development of other drugs exhibiting negative food effects, saving resources and bringing new drug products to the market faster.
In the context of data science, data projection and clustering are common procedures. The chosen analysis method is crucial to avoid faulty pattern recognition. It is therefore necessary to know the properties and especially the limitations of projection and clustering algorithms. This report describes a collection of datasets that are grouped together in the Fundamental Clustering and Projection Suite (FCPS). The FCPS contains 10 datasets with the names "Atom", "Chainlink", "EngyTime", "Golfball", "Hepta", "Lsun", "Target", "Tetra", "TwoDiamonds", and "WingNut". Common clustering methods occasionally identified non-existent clusters or assigned data points to the wrong clusters in the FCPS suite. Likewise, common data projection methods could only partially reproduce the data structure correctly on a two-dimensional plane. In conclusion, the FCPS dataset collection addresses general challenges for clustering and projection algorithms such as lack of linear separability, different or small inner class spacing, classes defined by data density rather than data spacing, no cluster structure at all, outliers, or classes that are in contact. This report describes a collection of datasets that are grouped together in the Fundamental Clustering and Projection Suite (FCPS). It is designed to address specific problems of structure discovery in high-dimensional spaces.
Photolabile protecting groups are widely used to trigger oligonucleotide activity. The ON/OFF‐amplitude is a critical parameter. An experimental setup has been developed to identify protecting group derivatives with superior caging properties. Bulky rests are attached to the cage moiety via Cu‐catalyzed azide–alkyne cycloaddition post‐synthetically on DNA. Interestingly, the decrease in melting temperature upon introducing o‐nitrobenzyl‐caged (NPBY‐) and diethylaminocoumarin‐cages (DEACM‐) in DNA duplexes reaches a limiting value. NMR spectroscopy was used to characterize individual base‐pair stabilities and determine experimental structures of a selected number of photocaged DNA molecules. The experimental structures agree well with structures predicted by MD simulations. Combined, the structural data indicate that once a sterically demanding group is added to generate a tri‐substituted carbon, the sterically less demanding cage moiety points towards the neighboring nucleoside and the bulkier substituents remain in the major groove.
Hexoses are the major source of energy and carbon skeletons for biosynthetic processes in all kingdoms of life. Their cellular uptake is mediated by specialized transporters, including glucose transporters (GLUT, SLC2 gene family). Malfunction or altered expression pattern of GLUTs in humans is associated with several widespread diseases including cancer, diabetes and severe metabolic disorders. Their high relevance in the medical area makes these transporters valuable drug targets and potential biomarkers. Nevertheless, the lack of a suitable high-throughput screening system has impeded the determination of compounds that would enable specific manipulation of GLUTs so far. Availability of structural data on several GLUTs enabled in silico ligand screening, though limited by the fact that only two major conformations of the transporters can be tested. Recently, convenient high-throughput microbial and cell-free screening systems have been developed. These remarkable achievements set the foundation for further and detailed elucidation of the molecular mechanisms of glucose transport and will also lead to great progress in the discovery of GLUT effectors as therapeutic agents. In this mini-review, we focus on recent efforts to identify potential GLUT-targeting drugs, based on a combination of structural biology and different assay systems.
Neurleptic drugs, e.g., aripiprazole, targeting the dopamine D2S and D3 receptors (D2SR and D3R) in the central nervous system are widely used in the treatment of several psychotic and neurodegenerative diseases. Therefore, a new series of benzothiazole-based ligands (3-20) was synthesized by applying the bioisosteric approach derived from the selective D3Rs ligand BP-897 (1) and its structurally related benz[d]imidazole derivative (2). Herein, introduction of the benzothiazole moiety was well tolerated by D2SR and D3R binding sites leading to antagonist affinities in the low nanomolar concentration range at both receptor subtypes. However, all novel compounds showed lower antagonist affinity to D3R when compared to that of 1. Further exploration of different substitution patterns at the benzothiazole heterocycle and the basic 4-phenylpiperazine resulted in the discovery of high dually acting D2SR and D3R ligands. Moreover, the methoxy substitution at 2-position of 4-phenylpiperazine resulted in significantly (22-fold) increased D2SR binding affinity as compared to the parent ligand 1, and improved physicochemical and drug-likeness properties of ligands 3-11. However, the latter structural modifications failed to improve the drug-able properties in ligands having un-substituted 4-phenylpiperazine analogs (12-20). Accordingly, compound 9 showed in addition to high dual affinity at the D2SR and D3R [Ki (hD2SR) = 2.8 ± 0.8 nM; Ki (hD3R) = 3.0 ± 1.6 nM], promising clogS, clogP, LE (hD2SR, hD3R), LipE (hD2SR, hD3R), and drug-likeness score values of −4.7, 4.2, (0.4, 0.4), (4.4, 4.3), and 0.7, respectively. Also, the deaminated analog 10 [Ki (hD2SR) = 3.2 ± 0.4 nM; Ki (hD3R) = 8.5 ± 2.2 nM] revealed clogS, clogP, LE (hD2SR, hD3R), LipE (hD2SR, hD3R) and drug-likeness score values of −4.7, 4.2, (0.4, 0.4), (3.9, 3.5), and 0.4, respectively. The results observed for the newly developed benzothiazole-based ligands 3-20 provide clues for the diversity in structure activity relationships (SARs) at the D2SR and D3R subtypes.
Enolase is a glycolytic enzyme, which catalyzes the inter-conversion of 2-phosphoglycerate to phosphoenolpyruvate. Altered expression of this enzyme is frequently observed in cancer and accounts for the Warburg effect, an adaptive response of tumor cells to hypoxia. In addition to its catalytic function, ENO-1 exhibits other activities, which strongly depend on its cellular and extracellular localization. For example, the association of ENO-1 with mitochondria membrane was found to be important for the stability of the mitochondrial membrane, and ENO-1 sequestration on the cell surface was crucial for plasmin-mediated pericellular proteolysis. The latter activity of ENO-1 enables many pathogens but also immune and cancer cells to invade the tissue, leading further to infection, inflammation or metastasis formation. The ability of ENO-1 to conduct so many diverse processes is reflected by its contribution to a high number of pathologies, including type 2 diabetes, cardiovascular hypertrophy, fungal and bacterial infections, cancer, systemic lupus erythematosus, hepatic fibrosis, Alzheimer’s disease, rheumatoid arthritis, and systemic sclerosis. These unexpected non-catalytic functions of ENO-1 and their contributions to diseases are the subjects of this review.
Living matter is defined by metastability, implying a tightly balanced synthesis and turnover of cellular components. The first step of eukaryotic protein degradation via the ubiquitin-proteasome system (UPS) leads to peptides, which are subsequently degraded to single amino acids by an armada of proteases. A small fraction of peptides, however, escapes further cytosolic destruction and is transported by ATP-binding cassette (ABC) transporters into the endoplasmic reticulum (ER) and lysosomes. The ER-resident heterodimeric transporter associated with antigen processing (TAP) is a crucial component in adaptive immunity for the transport and loading of peptides onto major histocompatibility complex class I (MHC I) molecules. Although the function of the lysosomal resident homodimeric TAPL-like (TAPL) remains, until today, only loosely defined, an involvement in immune defense is anticipated since it is highly expressed in dendritic cells and macrophages. Here, we compare the gene organization and the function of single domains of both peptide transporters. We highlight the structural organization, the modes of substrate binding and translocation as well as physiological functions of both organellar transporters.
Bitter taste receptors (TAS2Rs) are expressed in mucous epithelial cells of the tongue but also outside the gustatory system in epithelial cells of the colon, stomach and bladder, in the upper respiratory tract, in the cornified squamous epithelium of the skin as well as in airway smooth muscle cells, in the testis and in the brain. In the present work we addressed the question if bitter taste receptors might also be expressed in other epithelial tissues as well. By staining a tissue microarray with 45 tissue spots from healthy human donors with an antibody directed against the best characterized bitter taste receptor TAS2R38, we observed an unexpected strong TAS2R38 expression in the amniotic epithelium, syncytiotrophoblast and decidua cells of the human placenta. To analyze the functionality we first determined the TAS2R38 expression in the placental cell line JEG-3. Stimulation of these cells with diphenidol, a clinically used antiemetic agent that binds TAS2Rs including TAS2R38, demonstrated the functionality of the TAS2Rs by inducing calcium influx. Restriction enzyme based detection of the TAS2R38 gene allele identified JEG-3 cells as PTC (phenylthiocarbamide)-taster cell line. Calcium influx induced by PTC in JEG-3 cells could be inhibited with the recently described TAS2R38 inhibitor probenecid and proved the specificity of the TAS2R38 activation. The expression of TAS2R38 in human placental tissues points to further new functions and hitherto unknown endogenous ligands of TAS2Rs far beyond bitter tasting.